期刊文献+

左旋卡尼汀联合应用EPO治疗肾性贫血临床观察 被引量:2

The clinic treatment effect of L-carnitine and EPO on renal anemia in hemodialysis patien
暂未订购
导出
摘要 目的:观察左旋卡尼汀联合应用促红细胞生成素(EPO)治疗肾性贫血的疗效观察。方法:30例维持性血液透析患者随机分为两组,A组给予EPO及左旋卡尼汀治疗,B组给予EPO及等容积生理盐水作为对照,治疗前、后第4,8周测定血红蛋白及血细胞比容。结果:A组患者的血红蛋白及血细胞比容水平显著高于B组(P〈0.05),且A组的EPO平均用量明显少于B组(P〈0.05)。结论:左旋卡尼汀联合应用EPO可以改善肾性贫血,提高EPO疗效,可以减少EPO的用量。 Objective: To observ the clinical effect of L-carnitine plus erythropoietin (EPO) on nephritic anemia. Methods:Thirty maintenance hemodialysis patients were randomly divided into 2 groups. Group A were treated with L-carnitine plus EPO. Group B as the control group were treated with EPO plus same volum sodium. Hemoglobin (Hb) and hematocrit (Hct) levels were detected before and after treatmen. Results :Compared with group B,Hb and Hct levels increased significantly in group A(P〈0. 05) ,and the average dosage of EPO in group A was significantly lower than that in group B(P〈0.05). Conclusion :L-earnitine could improve the effect of EPO in the treatment of patients with nephritic anemia and reduce the dosage of EPO.
作者 苏华丰 梁宇
出处 《临床医药实践》 2009年第5期329-331,共3页 Proceeding of Clinical Medicine
关键词 左旋卡尼汀 促红细胞生成素 血液透析 肾性贫血 L-carnitine erythropoietin hemodialys renal anemia
  • 相关文献

参考文献2

二级参考文献6

  • 1Sikole A, Spasovski G, Zafirov D, et al. Epoetin omega for treatment of anemia in maintenance hemodialysis[J]. Clin Nephrol, 2002,57(3): 237-245.
  • 2Ma JZ, Ebbon J, Xiz H, et al. Hematocrit level and associated mortality in hemodialysis patients[J] . J Am Soc Nehprol, 1999, 10(3): 610-619.
  • 3Matsumoto Y, Amano I, Hirose S, et al. Effect of L-carnitine supplementation on renal anemia in poor responders to erythropoietin[J]. Blood Purif, 2001, 19(1): 24-32.
  • 4Ecans AM, Faull R, Fornasipo G, et al. Pharmocokinetic of L-carnitine in patients with end stage renal disease undergoing longterm hemodialysis[J]. Clin Pharmacol Ther, 2000, 68(3): 238-245.
  • 5Sotirakopoulos N, Athanasiou G, Tsitsios T, et al. The influence of L-carnitine supplementation on hematocrit and hemoglobin levels in patients with end stage renal failure on CAPD[J]. Ren Fail, 2001,24(1): 510-512.
  • 6Vesela E, Racek J, Trefil L, et al. Effect of L-carnitine supplementation in hemodialysis patients[J]. Nephron,2001,88(3): 218-223.

共引文献10

同被引文献22

引证文献2

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部